These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2576425)
1. Association of elevated expression of the c-erbB-2 protein with spread of breast cancer. Yamada Y; Yoshimoto M; Murayama Y; Ebuchi M; Mori S; Yamamoto T; Sugano H; Toyoshima K Jpn J Cancer Res; 1989 Dec; 80(12):1192-8. PubMed ID: 2576425 [TBL] [Abstract][Full Text] [Related]
2. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058 [TBL] [Abstract][Full Text] [Related]
3. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762 [TBL] [Abstract][Full Text] [Related]
4. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Odagiri E; Kanada N; Jibiki K; Demura R; Aikawa E; Demura H Cancer; 1994 Jun; 73(12):2978-84. PubMed ID: 7911069 [TBL] [Abstract][Full Text] [Related]
5. c-erbB-2 amplification in node-negative human breast cancer. Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424 [TBL] [Abstract][Full Text] [Related]
6. Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer. Babiak J; Hugh J; Poppema S Cancer; 1992 Aug; 70(4):770-6. PubMed ID: 1353701 [TBL] [Abstract][Full Text] [Related]
7. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR. Knyazev PG; Imyanitov EN; Chernitca OI; Nikiforova IF; Hanson KP Oncology; 1992; 49(2):162-5. PubMed ID: 1349430 [TBL] [Abstract][Full Text] [Related]
8. c-erbB-2 expression in breast cancer detected by immunoblotting and immunohistochemistry. Kerns BJ; Pence JC; Huper G; Kinney RB; Iglehart JD J Histochem Cytochem; 1990 Dec; 38(12):1823-30. PubMed ID: 1979342 [TBL] [Abstract][Full Text] [Related]
10. [C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor]. Manavi M; Czerwenka KF; Zeillinger R; Speiser P; Kury F; Steinhart U; Peschke M; Kubista E; Reinold E Zentralbl Gynakol; 1992; 114(2):82-5. PubMed ID: 1350129 [TBL] [Abstract][Full Text] [Related]
11. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma. Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268 [TBL] [Abstract][Full Text] [Related]
12. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer. King CR; Swain SM; Porter L; Steinberg SM; Lippman ME; Gelmann EP Cancer Res; 1989 Aug; 49(15):4185-91. PubMed ID: 2568168 [TBL] [Abstract][Full Text] [Related]
14. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420 [TBL] [Abstract][Full Text] [Related]
15. Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Iglehart JD; Kraus MH; Langton BC; Huper G; Kerns BJ; Marks JR Cancer Res; 1990 Oct; 50(20):6701-7. PubMed ID: 2208136 [TBL] [Abstract][Full Text] [Related]
16. p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade. Tsuda H; Iwaya K; Fukutomi T; Hirohashi S Jpn J Cancer Res; 1993 Apr; 84(4):394-401. PubMed ID: 8099903 [TBL] [Abstract][Full Text] [Related]
17. [Preliminary studies on c-erbB-2 protooncogene in breast cancer]. He LW Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):171-4. PubMed ID: 1356719 [TBL] [Abstract][Full Text] [Related]
18. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease. Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395 [TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of ErbB-2 protein in tissue extract using an enzyme immuno assay (ErbB-2 EIA "Nichirei")]. Sugano K; Kitajima M; Ishii M; Koyama H; Kasumi F; Demura R; Mori S; Ohkura H Gan To Kagaku Ryoho; 1994 Sep; 21(12):1957-66. PubMed ID: 7916182 [TBL] [Abstract][Full Text] [Related]
20. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. Gaffey MJ; Frierson HF; Williams ME Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]